About Zellik Pharma
Zellik Pharma is a private limited company (BV/SRL) based in Asse, founded in 2006. Its main activity is classified as "Detailhandel in farmaceutische producten". For the 2025 financial year, Zellik Pharma reported a profit of €389. A year earlier, in 2024, it still made a loss of €93,373. Revenue was not published, which is common for abbreviated accounts. The gross margin came to €336,913, down 14% on 2024. Equity stands at €442,955, a solvency ratio of 35%. In 2007 it was €10,513. 18 annual accounts are available, covering 2007 to 2025.
- Sectors
- Pharmacies
- Signals
-
ProfitableProfitable € 389
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 443KStrong equity provides a buffer against setbacks.
Low riskLow risk 35.4%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 1.53A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 21KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 25KPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 8.9%Social debts stay manageable relative to personnel costs.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
337K
|
€
394K
|
€
623K
|
€
599K
|
|
|
€
25K
|
€
-66K
|
€
124K
|
€
177K
|
|
|
€
389
|
€
-93K
|
€
69K
|
€
110K
|
|
|
€
443K
|
€
443K
|
€
536K
|
€
467K
|
|
|
35.43%
|
37.81%
|
48.02%
|
39.45%
|
|
|
€
807K
|
€
728K
|
€
580K
|
€
717K
|
|
|
€
413
|
€
12K
|
€
5K
|
€
3K
|
|
|
0
|
8
|
9.30
|
9.10
|
Publications 24
All publications- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Wijziging Rechtsvorm - Ontslagen - Benoemingen 10/01/2024
- Ontslagen - Benoemingen 03/01/2023
- Ontslagen - Benoemingen 02/04/2019
- Ontslagen - Benoemingen 18/12/2018
- Ontslagen - Benoemingen 02/08/2018
Frequently asked questions
Answers to the most common questions about Zellik Pharma, based on official government data and the filed annual accounts.
What is the VAT number of Zellik Pharma?
The VAT number of Zellik Pharma is BE0881.910.538.
How many employees work at Zellik Pharma?
In 2025, Zellik Pharma employed 0.00 full-time equivalents (FTE).
When was Zellik Pharma established?
Zellik Pharma was founded in 16-06-2006.
What is the official address of Zellik Pharma?
The official address of Zellik Pharma is Brusselsesteenweg 812 Asse 1731.
What is the legal form of Zellik Pharma?
The juridical form of Zellik Pharma is Private limited company (BV/SRL).
What is the annual revenue of Zellik Pharma?
The 2025 accounts of Zellik Pharma do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Zellik Pharma a reliable company?
Zellik Pharma is a registered Rechtspersoon with company number 0881.910.538 and can be verified through the official CBE database.
What is the credit limit of Zellik Pharma?
The estimated credit limit of Zellik Pharma is €38,958.
Is Zellik Pharma still active?
Zellik Pharma currently has the status "Normal situation" and is active.